HF
TEVA icon

HRT Financial’s Teva Pharmaceuticals TEVA Stock Holding History

HRT Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
295,918
+155,696
+111% +$5.19M 0.02% 780
2026
Q1 		$4.22M Buy
140,222
+127,457
+998% +$4.1M 0.01% 1110
2025
Q4 		$398K Buy
+12,765
New +$314K ﹤0.01% 2227
2023
Q4 		– Sell
-32,711
Closed -$333K – 3066
2023
Q3 		$333K Sell
32,711
-11,275
-26% -$105K ﹤0.01% 1609
2023
Q2 		$331K Buy
43,986
+13,027
+42% +$106K ﹤0.01% 1564
2023
Q1 		$273K Buy
+30,959
New +$306K ﹤0.01% 1768
2022
Q3 		– Sell
-34,427
Closed -$258K – 3497
2022
Q2 		$258K Buy
+34,427
New +$300K ﹤0.01% 2118
2021
Q3 		– Sell
-25,944
Closed -$256K – 3747
2021
Q2 		$256K Sell
25,944
-8,865
-25% -$93.8K ﹤0.01% 2249
2021
Q1 		$401K Buy
34,809
+16,122
+86% +$185K ﹤0.01% 1948
2020
Q4 		$180K Buy
+18,687
New +$179K ﹤0.01% 1516
2020
Q2 		– Sell
-16,105
Closed -$144K – 1752
2020
Q1 		$144K Buy
+16,105
New +$165K 0.01% 603
2019
Q4 		– Sell
-15,400
Closed -$105K – 1629
2019
Q3 		$105K Buy
+15,400
New +$118K 0.01% 1243
2019
Q2 		– Sell
-25,491
Closed -$399K – 910
2019
Q1 		$399K Sell
25,491
-10,002
-28% -$176K 0.06% 232
2018
Q4 		$547K Buy
+35,493
New +$728K 0.08% 200

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

HRT Financial's TEVA Position: Q2 2026 in Review

HRT Financial increased its Teva Pharmaceuticals (TEVA) stake by 111% in Q2 2026, buying an estimated $5.19M and bringing the position to 295,918 shares worth $10M. The position accounts for 0.02% of the portfolio, ranked #780.

HRT Financial first reported a position in TEVA in Q4 2018 and has held it in 14 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • HRT Financial held 295,918 shares of Teva Pharmaceuticals worth $10M as of Q2 2026.
  • HRT Financial bought 155,696 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.19M.
  • Teva Pharmaceuticals made up 0.02% of HRT Financial's portfolio in Q2 2026, its #780 holding.
  • HRT Financial first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.